Home
Resources
Publications
ORM-10103: A Significant Advance in Sodium-Calcium Exchanger Pharmacology?

ORM-10103: A Significant Advance in Sodium-Calcium Exchanger Pharmacology?

C M Terracciano, J C Hancox

Br J Pharmacol. 2013 Oct;170(4):765-7.

PMID: 23848255

Abstract:

The sodium-calcium exchanger (NCX) is an electrogenic transporter that is widely expressed in different tissues. In the heart, the NCX plays important roles in calcium ion homeostasis, excitation-contraction coupling and the electrophysiological properties of cardiac myocytes. Precise determination of the roles of the NCX has somewhat been hampered by a lack of selective small molecule inhibitors. In this issue of the BJP, Jost and colleagues present data on a new NCX inhibitor, ORM-10103, which has submicromolar EC50 values against cardiac forward and reverse exchange activity. The compound exhibits improved selectivity over existing small molecule NCX inhibitors and, in particular, appears to be without effect on L-type calcium channels at high concentrations. ORM-10103 could therefore have significant value for studies of the (patho)physiological roles of the NCX in the heart. Further pharmacological studies are required to investigate the actions of ORM-10103 on cardiac cells and tissues and to determine its effects on non-cardiac NCX isoforms.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP488847285	ORM-10103		488847-28-5	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: